We have a solution for everything – and the corresponding experience. In our current seven areas of expertise, we are at your disposal with our comprehensive know-how.

All Solutions

Software solutions

Software solutions

With our Werum PAS-X MES - on premise or cloud-based - and our software solutions for analysis, track & trace, networked factories, and intelligent packaging, we are the world's leading supplier and partner to the pharmaceutical and biotech industries.

Overview Software solutions

Handling systems

Handling systems

We are specialists for complete handling systems for pharmaceutical and medical products. Our solutions are decisive in the field of contactless and safe transport of e.g. glass syringes.

Overview Handling systems

Inspection machines


As the world's leading inspection expert, we develop solutions for the pharmaceutical and biotech industries. Our range of products extends from high-performance machines and semi-automatic machines to laboratory units and inspection applications for in-process control.

Overview Inspection

Machine finder

Packaging machines

Packaging machines

We are a leading supplier of packaging machines for liquid and solid pharmaceutical and medical products. With our blister, sachet and stick packaging machines we offer solutions for primary packaging. Our side and topload cartoners set standards worldwide for secondary packaging.

Overview Packaging machines

K.Pak Topload Case Packer

Introducing our latest solution from Körber; the K.Pak Topload Case Packer! Created specifically for the pharmaceutical industry, the K.Pak solution provides operator-friendly machines to complete any production line. Our solution focuses on innovative technology, high-quality design and expert handling and packaging of your product. It’s time to start connecting the dots with Körber!

Packaging solutions

Packaging solutions

As long-standing specialists, we develop packaging solutions for innovative and high-quality secondary pharmaceutical packaging made of cardboard. We offer you solutions for counterfeit protection, standard folding boxes and much more.

Overview Packaging solutions



Our experts will advise you during the analysis of your requirements, show you optimisation potential and support you during the implementation of projects in all areas of the pharmaceutical, biotech and medical device industry.

Overview Consulting


Shaping the future of pharma manufacturing

While the pharmaceutical industry is measured by its commitment to improve patients' quality of life, manufacturers simultaneously face an increasingly complex situation.

Among the key requirements are safeguarding and tracing supply chains, maintaining consistently high product quality and data integrity, ensuring smooth process development and technology transfer, accelerating time to market, as well as coping with persistent cost pressures. The industry must evolve to meet these challenges, managing the complexity of drug manufacturing, and serving patients even better.

Defining standards for the industry – Körber experts engage in industry associations

To help shaping the future of pharma manufacturing, Körber actively engages in various industry associations such as the International Society for Pharmaceutical Engineering (ISPE), the Parenteral Drug Association (PDA), the BioPhorum, and the Indian Drug Manufacturers Association (IDMA)

In these organizations, industry leaders and subject matter experts from the pharmaceutical and biotech industries collaborate to develop solutions for current problems. Our experts chair and participate in working groups, curate conferences, and deliver keynote presentations. In this way, together with the community we help define new processes and standards for the industry.

Introducing Pharma 4.0

As an ISPE Gold Corporate Partner, Körber is uniquely positioned to support the pharma and biotech industry, providing in-depth thought leadership and technical innovation to our clients. The contributions, insights, and participation of our experts in ISPE special interest groups and communities of practice represent a great opportunity to jointly address how our industry is evolving to meet the challenges ahead. 

It was our expert, Christian Wölbeling, who, along with other ISPE members, coined the concept of "Pharma 4.0" and is the founder and chairman of the ISPE Community of Practice "Pharma 4.0". Most recently Christian acted as one of the lead authors of the “ISPE Pharma 4.0 Baseline Guide”, covering the benefits of a holistic control strategy, quality management opportunities, and the foundational processes for an interconnected plant architecture.

lThe pharmaceutical industry is facing ever-increasing challenges. Our goal is to best support our customers on their digital transformation journey. Leveraging our profound pharma process expertise, our extensive network, and our tech vision for the future, we help them navigate the complexities of pharmaceutical and biotech production. We aim to be more than just a supplier – we strive to be a strategic partner to our customers.r

Stefan Münch, Vice President Validation & Qualification Consulting, Körber BA Pharma

How Körber emerged as a top ally of the PDA

Körber has tremendously evolved its partnership with the PDA over the past years. What began as a mere attendance to a certain conference has grown into a strategic collaboration. Today, we are proud to be a partner of the PDA in Europe, the US, and Asia-Pacific. 

As a result of this partnership, Körber has supported countless conferences, participated in lots of global committees, and has submitted myriad abstracts to share its latest thoughts with industry peers. We have expanded our engagement to new areas, such as packaging machines and materials, digital transformation, and sustainability.

lOur partnership with the PDA reflects our commitment to innovation and technology leadership in the pharmaceutical industry. We are honored to share our insights and expertise with our peers and learn from their best practices.r

Florian Kofler, Head of Product Management, Körber BA Pharma


We have also contributed our expertise to BioPhorum’s frequently referenced “Digital Plant Maturity Model”, a structured and straightforward tool to assess the digital maturity of pharmaceutical plants. Additionally, along with other authors, our experts Jamie Glasser and Dr. Judith Koliwer authored the BioPhorum publication "Standardizing Traceability of Personalized Cell and Gene Therapies" to develop an approach to traceability for cell and gene therapies across the entire value chain.

The voice of the Indian national industry

The IDMA brings together more than 1,000 leading Indian pharmaceutical companies. The industry association regularly hosts seminars, training programs, and workshops for the benefit of its members and the broader pharmaceutical industry. We play a vital role in the IDMA by empowering the Indian pharma community with knowledge and tools essential for navigating digital transformation in pharma manufacturing.

Developing products and solutions

Our active participation in associations and committees contributes to the continuous development of our products and services. For example, we provide PAS-X MSI Plug & Produce, an open, vendor-independent solution that provides a universal integration interface fully aligned with the standardization objectives of the ISPE Plug & Produce working group.

As an international technology group and a strategic partner, we offer our customers individual overall solutions for their factory of excellence. We do this by means of our sustainable ecosystem approach, in which we bring together the most important experts from all the relevant areas of our partner network. In the process, rather than emphasizing our individual products, we look at the holistic needs and visions of our customers to ensure their sustained success. In the field of cell & gene therapy, for instance, we partner with leading providers such as HyperTrust and TrakCel to establish standardized interfaces between manufacturing and logistics. 

We deliver the difference in pharma. Let us guide you on your digital transformation journey to elevate your business.

Whitepaper: Addressing Cell and Gene Therapy Manufacturing Challenges with Digital Solutions

The increasing demand for CGT requires scaling of production pipelines. Digital solutions are needed to support commercial production. In our whitepaper, we analyze the impact of Pharma 4.0 on CGT manufacturing and look at different options such as cloud-based and software-as-a-service offerings.


This could also interest you:

Interview: Industry leaders – Bringing Pharma 4.0™ into the world

Discover the origins of Pharma 4.0™ and learn how Christian Wölbeling, alongside other ISPE members, tirelessly works to define the industry's progression toward a holistic control strategy.

Read more

Video: Cell & Gene Therapy digital transformation

Join Dr. Judith Koliwer in understanding how CGT companies are overcoming major challenges by digitalizing their processes and advancing towards commercial manufacturing.

Watch now

Video: Global Connext – Mercks’ journey from MANUfacturing to SMARTfacturing

Join us for an exclusive recording of Michelangelo Canzoneri's Global Connext keynote, where he talks about Merck's incredible journey from traditional manufacturing to so-called SMART manufacturing.

Watch now


No comments

Write comment

* These fields are required

Back to top
Back to top